Patients with SLE demonstrate increased serum concentrations of the satiety hormone leptin [112], whereas leptin is also implicated in the promotion of SLE, by increasing the production of autoantibodies, exhibiting a strong correlation to disease activity and inhibiting immune regulation [112,113,114]. The gene discussed is LEP; the disease is systemic lupus erythematosus.